711
Participants
Start Date
November 6, 2014
Primary Completion Date
October 5, 2015
Study Completion Date
October 5, 2015
Lifitegrast
Lifitegrast Ophthalmic Solution 5%, BID for 84 days
Placebo
Placebo to match active treatment, BID for 84 days
Clinical Vision Research Center at SUNY, New York
Ophthalmic Consultants Of Long Island, Rockville Centre
South Shore Eye Care, LLP, Wantagh
Scott & Christie and Associates, PC, Cranberry Township
Matossian Eye Associates, Doylestown
See Clearly Vision, McLean
University of Alabama at Birmingham, UAB School of Optometry, Birmingham
Toyos Clinic, Nashville
The Eye Care Institute, Louisville
Koffler Vision Group, Lexington
Holpro Vision, Ltd., Union
Abrams Eye Center, Cleveland
Price Vision Group, Indianapolis
John-Kenyon American Eye Institute, New Albany
Jackson Eye, SC, Lake Villa
Chicago Cornea Consultants, Ltd., Hoffman Estates
Lifelong Vision Foundation, Chesterfield
Comprehensive Eye Care, Ltd., Washington
Tekwani Vision Center, St Louis
Ophthalmology Consultants, Ltd., St Louis
Tauber Eye Center, Kansas City
Advanced Laser Vision and Surgical Institute, Houston
Whitsett Vision Group, Houston
University of Houston College of Optometry, Houston
The Eye Clinic of Texas (Houston Eye Associates), League City
Eye Clinics of South Texas, P.A., San Antonio
R and R Eye Research, LLC., San Antonio
The Cataract & Glaucoma Center, El Paso
Arizona Eye Center, Chandler
Wellish Vision Institute, Las Vegas
Abrams Eye Institute, Las Vegas
United Medical Research Institute, Inglewood
Montebello Medical Eye Center, Inc., Montebello
Sall Research Medical Center, Artesia
North Valley Eye Medical Group, Inc, Mission Hills
Arch Health Partners, Poway
West Coast Eye Care Associates, San Diego
Eye Research Foundation, Newport Beach
Martel Eye Medical Group, Rancho Cordova
Shasta Eye Medical Group, Inc., Redding
Clinical Eye Research of Boston, Winchester
Lead Sponsor
Shire
INDUSTRY